TLC Diversified Revenue and Competitors

Claim your profile

Palmetto, FL USA

Location

N/A

Total Funding

Construction

Industry

Estimated Revenue & Valuation

  • TLC Diversified's estimated annual revenue is currently $24.9M per year.(i)
  • TLC Diversified's estimated revenue per employee is $290,000

Employee Data

  • TLC Diversified has 86 Employees.(i)
  • TLC Diversified grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$17.5M67-3%N/AN/A
#2
$77.5M243N/AN/AN/A
#3
$11.6M50-14%N/AN/A
#4
$1.2M8N/AN/AN/A
#5
$18M69-4%N/AN/A
#6
$5.9M290%N/AN/A
#7
$85.5M268N/AN/AN/A
#8
$50.7M159-6%N/AN/A
#9
$10.9M47-15%N/AN/A
#10
$18M69N/AN/AN/A

TLC Diversified is one of the leading privately held construction firms in the state of Florida specializing in water and wastewater infrastructure. We take great pride in exceeding the expectations of our clients, employees, partners and communities. Our mission, since 1985, is to provide timely completion of the best quality construction under the safest conditions. Since its inception, TLC has focused on the construction of water treatment plants, wastewater treatment plants, pump stations and lift stations. We are licensed in Florida as well as Iowa. Work with us and you will see that we dont just advertise our values: We live them.

keywords:N/A

N/A

Total Funding

86

Number of Employees

$24.9M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TLC Diversified News

08/29/2019 - Taiwan Liposome Company Ltd ADR (TLC): Indicator Watch ...

Taiwan Liposome Company Ltd ADR (TLC): Indicator Watch on Company ... The diligent investor typically has a portfolio that is diversified and ...

08/21/2019 - Global Laminator Market 2018 – Apache, INTEY, Zoomyo, 3M ...

... players [Apache, INTEY, Zoomyo, 3M, SARKI, Xyron, TLC] who are ... based on which the global Laminator market has been diversified.

08/22/2019 - Global Thymic Carcinoma Treatment Market Research 2019 ...

... Market, by Type : Belinostat, Pasireotide ER, Milciclib, TLC-388, Others ... Vendors are providing a diversified range of product lines ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$30.1M1379%N/A
#2
$22.6M1372%N/A
#3
$145.8M4328%N/A
#4
$423M14741%N/A
#5
N/A30745%N/A